Sunesis Pharmaceuticals, Inc. (SNSS) Expands Hematology Franchise With Global Licenses To Two Kinase Inhibitor Programs
1/9/2014 9:57:39 AM
SOUTH SAN FRANCISCO, Calif., Jan. 9, 2014 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that it has expanded its hematology franchise through separate global licensing agreements for two preclinical kinase inhibitor programs. The company will host a conference call to discuss these agreements, as well as an outlook for 2014, today at 11:00 a.m. Eastern Time.
Help employers find you! Check out all the jobs and post your resume.
comments powered by